NLS Pharmaceutics AG
NASDAQ:NLSP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
CH |
|
O
|
OrganoClick AB
STO:ORGC
|
SE |
|
S
|
Shriram Properties Ltd
NSE:SHRIRAMPPS
|
IN |
|
Afyon Cimento Sanayi TAS
IST:AFYON.E
|
TR |
|
M
|
Multibax PCL
SET:MBAX
|
TH |
|
Roivant Sciences Ltd
F:87S
|
UK |
NLS Pharmaceutics AG
NLS Pharmaceutics Ltd. engages in the discovery and development of drug therapies to treat rare and complex central nervous systems disorders, including narcolepsy, idiopathic hypersomnia and other rare sleep disorders, and of neurodevelopmental disorders, such as Attention Deficit Hyperactivity Disorder. The company is headquartered in Stans, Nidwalden and currently employs 6 full-time employees. The firm focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The firm serves customers worldwide.
NLS Pharmaceutics Ltd. engages in the discovery and development of drug therapies to treat rare and complex central nervous systems disorders, including narcolepsy, idiopathic hypersomnia and other rare sleep disorders, and of neurodevelopmental disorders, such as Attention Deficit Hyperactivity Disorder. The company is headquartered in Stans, Nidwalden and currently employs 6 full-time employees. The firm focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The firm serves customers worldwide.
